• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY Back to Search Results
Model Number 180343
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Electrolyte Imbalance (2196); Hypervolemia (2664)
Event Date 07/01/2022
Event Type  Injury  
Event Description
It was reported to fresenius that this patient with end stage renal disease (esrd) on continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt) was hospitalized due to high potassium levels (hyperkalemia) and retaining ¿a lot¿ of fluid (fluid retention).The patient reported they were discharged, after which they presented to the outpatient dialysis center to evaluate the functionality of their pd catheter (not a fresenius product).The pd catheter allegedly functioned as intended during manual testing (medical interpretation of evaluation unknown), thus the patient contacted fresenius technical support requesting a replacement liberty select cycler due to slow drains.Subsequent attempts to obtain additional information (e.G., discharge summary, hospital records, treatment data) have thus far proven unsuccessful.
 
Manufacturer Narrative
A temporal relationship exists between ccpd therapy utilizing the liberty select cycler and the serious adverse events of hyperkalemia and fluid retention, which required hospitalization (unknown duration).Multiple attempts were made to obtain additional information regarding the serious adverse events; however, no response was received.This lack of information precluded a more comprehensive investigation; therefore, limiting the possibility of establishing causality.Fluid retention and electrolyte imbalances are common and often preventable processes in esrd patients and are likely multifactorial in origin.Additionally, catheter related considerations, such as position, obstruction, omental wrapping, and fibrin can all be contributing factors.Based on the limited information available, the liberty select cycler cannot be disassociated from the events.There is currently no documentation or objective evidence indicating a fresenius device(s) and/or product(s) deficiency or malfunction occurred causing the serious adverse events.Nevertheless, due to the lack of follow-up information (e.G., hospital records, discharge summary, patient demographics, treatment data), the liberty select cycler cannot be excluded from having a possible contributory role in the events.However, it should be noted if the cycler is returned, a manufacturer evaluation may disassociate the liberty select cycler from having contributed to the serious adverse events.The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Manufacturer Narrative
Plant investigation: no parts were returned to the manufacturer for physical evaluation.A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformances, or any associated rework identified during the manufacturing process which could be related to the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The investigation into the cause of the reported problem was not able to be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
 
Event Description
It was reported to fresenius that this patient with end stage renal disease (esrd) on continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt) was hospitalized due to high potassium levels (hyperkalemia) and retaining ¿a lot¿ of fluid (fluid retention).The patient reported they were discharged, after which they presented to the outpatient dialysis center to evaluate the functionality of their pd catheter (not a fresenius product).The pd catheter allegedly functioned as intended during manual testing (medical interpretation of evaluation unknown), thus the patient contacted fresenius technical support requesting a replacement liberty select cycler due to slow drains.Subsequent attempts to obtain additional information (e.G., discharge summary, hospital records, treatment data) have thus far proven unsuccessful.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIBERTY SELECT CYCLER ASSY(NON-VALUATED)
Type of Device
SYSTEM, PERITONEAL, AUTOMATIC DELIVERY
Manufacturer (Section D)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer (Section G)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key15182480
MDR Text Key297414400
Report Number0002937457-2022-01314
Device Sequence Number1
Product Code FKX
UDI-Device Identifier00840861102068
UDI-Public00840861102068
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181108
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 08/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number180343
Device Catalogue NumberRTLR180343
Was Device Available for Evaluation? No
Device AgeMO
Initial Date Manufacturer Received 07/18/2022
Initial Date FDA Received08/08/2022
Supplement Dates Manufacturer Received08/10/2022
Supplement Dates FDA Received08/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/23/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
DELFLEX PD FLUID; DELFLEX PD FLUID; LIBERTY CYCLER SET; LIBERTY CYCLER SET
Patient Outcome(s) Required Intervention; Hospitalization;
Patient SexMale
-
-